Evidence map›Paper›PMID 30467011›Full record

ArticleEBioMedicine2019

Increased urinary exosomal microRNAs in children with idiopathic nephrotic syndrome.

Tingting Chen, Cheng Wang, Hanqing Yu, Meng Ding, Cuiping Zhang, Xiaolan Lu, Chen-Yu Zhang, Chunni Zhang

Open access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. miR-148b-5p regulates hypercalciuria and calcium-containing nephrolithiasis.Cellular and molecular life sciences : CMLS · 2024
    Article
  9. Urinary extracellular vesicles in childhood kidney diseases.Pediatric nephrology (Berlin, Germany) · 2024
    Review
  10. Review
  11. Article
  12. Urinary podocyte-derived large extracellular vesicles are increased in paediatric idiopathic nephrotic syndrome.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Article
  13. Extracellular Vesicle MicroRNA in the Kidney.Comprehensive Physiology · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Tingting ChenDepartment of Clinical Laboratory, Jinling Hospital, Nanjing School of Clinical Medicine, Southern Medical University, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing, China; State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Advance Research Institute of Life Sciences, Nanjing University, School of Life Sciences, Nanjing, China.
Cheng WangDepartment of Clinical Laboratory, Jinling Hospital, Nanjing School of Clinical Medicine, Southern Medical University, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing, China; State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Advance Research Institute of Life Sciences, Nanjing University, School of Life Sciences, Nanjing, China.
Hanqing YuDepartment of Clinical Laboratory, Nanjing Children's Hospital, Nanjing, China.
Meng DingState Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Advance Research Institute of Life Sciences, Nanjing University, School of Life Sciences, Nanjing, China.
Cuiping ZhangDepartment of Clinical Laboratory, Jinling Hospital, Nanjing School of Clinical Medicine, Southern Medical University, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing, China.
Xiaolan LuDepartment of Clinical Laboratory, Jinling Hospital, Nanjing School of Clinical Medicine, Southern Medical University, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing, China; State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Advance Research Institute of Life Sciences, Nanjing University, School of Life Sciences, Nanjing, China.
Chen-Yu ZhangState Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Advance Research Institute of Life Sciences, Nanjing University, School of Life Sciences, Nanjing, China. Electronic address: cyzhang@nju.edu.cn.
Chunni ZhangDepartment of Clinical Laboratory, Jinling Hospital, Nanjing School of Clinical Medicine, Southern Medical University, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing, China; State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Advance Research Institute of Life Sciences, Nanjing University, School of Life Sciences, Nanjing, China. Electronic address: zchunni27@hotmail.com.
Nanjing University · CNNanjing General Hospital of Nanjing Military Command · CNNanjing Children's Hospital · CNSouthern Medical University · CNState Key Laboratory of Analytical Chemistry for Life Science

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUrinary exosomal miRNAs are gaining increasing attention for their potential as ideal non-invasive biomarkers for kidney diseases; however, little is known about their diagnostic ability for paediatric nephrotic syndrome (NS). This study explored the clinical value of urinary exosomal miRNAs for paediatric idiopathic NS.

methodsUrine samples were collected from 129 NS children and 126 age-/sex-matched healthy controls. The miRNA profile of urinary exosomes was analysed by high-throughput Illumina sequencing via synthesis (SBS) technology followed by verification with a quantitative reverse-transcription polymerase chain reaction (RT-qPCR) assay arranged in two independent cohorts. Additionally, paired urine samples from 65 of these patients were collected before and after treatment.

findingsThe Illumina SBS identified 30 markedly increased urinary exosomal miRNAs in NS children compared with controls (≥ 5-fold, P < .05). Fifteen miRNAs were selected for further investigation, of which 5 (miR-194-5p, miR-146b-5p, miR-378a-3p, miR-23b-3p and miR-30a-5p) were verified by RT-qPCR to be significantly and steadily increased in NS (> 3-fold, P < .01) and markedly reduced during the clinical remission period (P < .001). Moreover, the concentrations of miR-194-5p and miR-23b-3p were significantly positively correlated with the urine protein content and were markedly higher in the high urine protein group than in the low urine protein group (P < .001 and P < .01, respectively). INTERPRETATIONS: We identified 5 altered urinary exosomal miRNAs in NS children with disease progression and treatment. These urinary exosomal miRNAs could be promising and non-invasive potential biomarker candidates for diagnosing, monitoring and stratifying paediatric NS. FUND: National Natural Science Foundation of China; Fund of State Key Laboratory of Analytical Chemistry for Life Science; National Basic Research Programme of China; Foundation of Jiangsu Provincial Medical Youth Talent.

Indexed as

Up-RegulationBiomarkers, TumorCase-Control StudiesDisease ProgressionExosomesFemaleGene Expression Regulation, NeoplasticHigh-Throughput Nucleotide SequencingHumansMaleMicroRNAsNephrotic SyndromeSequence Analysis, RNABiomarkers, TumorMicroRNAsBiomarkerIllumina sequencing via synthesismicroRNAPaediatric idiopathic nephrotic syndromeRT-qPCRUrinary exosomes

Identifiers

PMID30467011
PMCPMC6355644
OpenAlexW2900512548

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.